Terumo (OTCMKTS:TRUMY) Shares Gap Down - Should You Sell?

Key Points

• Shares gapped down — Terumo opened at $13.13 after a $13.99 close and was last trading around $13.57 on light volume (4,472 shares).
• Earnings mixed — the company reported $0.14 EPS (missed by $0.01) while revenue of $1.94 billion topped estimates of $1.82 billion, with a net margin of 11.74% and ROE of 9.01%.
• Analyst and valuation context — Nomura moved the stock to a "hold" (consensus rating: Hold); the 50-day MA is $13.16 versus the 200-day MA of $14.62, market cap about $20.13B and P/E ~23.5.

Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $13.99, but opened at $13.13. Terumo shares last traded at $13.57, with a volume of 4,472 shares traded.

Analyst Ratings Changes

Separately, Nomura raised shares of Terumo to a "hold" rating in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has an average rating of "Hold".

Terumo Price Performance

The company's fifty day moving average is $13.16 and its 200 day moving average is $14.62. The firm has a market cap of $20.13 billion, a price-to-earnings ratio of 23.53 and a beta of 0.72. The company has a quick ratio of 0.89, a current ratio of 1.51 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its earnings results on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Terumo had a return on equity of 9.01% and a net margin of 11.74%.The business had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.82 billion.

Terumo Company Profile

Terumo Corporation OTCMKTS: TRUMY is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.